323
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing

, , , , &
Pages 896-903 | Received 20 Jan 2013, Accepted 20 Mar 2013, Published online: 30 Apr 2013

References

  • Borenstein JT. Intracochlear drug delivery systems. Expert Opin Drug Deliv 2011;8:1161–74
  • Swan EE, Mescher MJ, Sewell WF, et al. Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008;60:1583–99
  • Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2004;2:389–403
  • Ahmed A. Antiviral treatment of cytomegalovirus infection. Infect Disord Drug Targets 2011;11:475–503
  • Rivera T, Sanz L, Camarero G, Varela-Nieto I. Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss. Curr Drug Deliv 2012;9:231–42
  • Barrs DM. Intratympanic corticosteroids for Meniere's disease and vertigo. Otolaryngol Clin North Am 2004;37:955–72
  • Barrs DM, Keyser JS, Stallworth C, McElveen JT Jr. Intratympanic steroid injections for intractable Meniere's disease. Laryngoscope 2001;111:2100–4
  • Dodson KM, Woodson E, Sismanis A. Intratympanic steroid perfusion for the treatment of Meniere's disease: a retrospective study. Ear Nose Throat J 2004;83:394–8
  • Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26: 878–81
  • Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 2004;37:1061–74
  • Shi J, Yang J, Wu H, et al. Intratympanic dexamethasone medication for sudden sensorineural hearing loss: clinical evaluation. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006;20:749–51
  • Bowe SN, Jacob A. Round window perfusion dynamics: implications for intracochlear therapy. Curr Opin Otolaryngol Head Neck Surg 2010;18:377–85
  • McCall AA, Swan EE, Borenstein JT, et al. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 2010;31:156–65
  • Horie RT, Sakamoto T, Nakagawa T, et al. Sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid microparticles. Laryngoscope 2010;120:377–83
  • Kelly RM, Meyer JD, Matsuura JE, et al. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm 1999;25:15–20
  • Paulson DP, Abuzeid W, Jiang H, et al. A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008;118:706–11
  • Piu F, Wang X, Fernandez R, et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 2011;32:171–9
  • Wang X, Dellamary L, Fernandez R, et al. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 2009;14:393–401
  • Koizumi T, Higuchi WI. Analysis of data on drug release from emulsions. II. Pyridine release from water-in-oil emulsions as a function of pH. J Pharm Sci 1968;57:87–92
  • Flynn GL, Smith EW. Membrane diffusion. I. Design and testing of a new multifeatured diffusion cell. J Pharm Sci 1971;60:1713–7
  • Kneczke M, Landersjo L, Lundgren P, Fuhrer C. In vitro release of salicylic acid from two different qualities of white petrolatum. Acta Pharm Suec 1986;23:193–204
  • Emami J. In vitro–in vivo correlation: from theory to applications. J Pharm Pharm Sci 2006;9:169–89
  • Qiao M, Chen D, Ma X, Liu Y. Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels. Int J Pharm 2005;294:103–12
  • Azarmi S, Roa W, Lobenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm 2007;328:12–21
  • Flynn GL, Shah VP, Tenjarla SN, et al. Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm Res 1999;16:1325–30
  • Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37–51
  • Zentner GM, Rathi R, Shih C, et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J Control Release 2001;72:203–15
  • Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997;36:201–11
  • Chelikh L, Teixeira M, Martin C, et al. High variability of perilymphatic entry of neutral molecules through the round window. Acta Otolaryngol 2003;123:199–202
  • Lundman L, Bagger-Sjoback D, Holmquist L, Juhn S. Round window membrane permeability: an in vitro model. Acta Otolaryngol 1988;457:73–7
  • Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14:350–60
  • Kanzaki S, Fujioka M, Yasuda A, et al. Novel in vivo imaging analysis of an inner ear drug delivery system in mice: comparison of inner ear drug concentrations over time after transtympanic and systemic injections. PLoS One 2012;7:e48480
  • Wang Y, Gao X, Kuriyavar S, et al. Incorporation, release, and effectiveness of dexamethasone in poly(lactic-co-glycolic acid) nanoparticles for inner ear drug delivery. J Nanotechnol Eng Med 2011;2:011013-1--7
  • Thaler M, Roy S, Fornara A, et al. Visualization and analysis of superparamagnetic iron oxide nanoparticles in the inner ear by light microscopy and energy filtered TEM. Nanomedicine 2011;7:360–9
  • Du X, Chen K, Kuriyavar S, et al. Magnetic targeted delivery of dexamethasone acetate across the round window membrane in guinea pigs. Otol Neurotol 2013;34:41–7
  • Mondalek FG, Zhang YY, Kropp B, et al. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J Nanobiotechnol 2006;4:4
  • Lee SH, Lee JE, Baek WY, Lim JO. Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo. J Control Release 2004;96:1–7
  • Salt AN, Hartsock J, Plontke S, et al. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol Neurootol 2011;16:323–35

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.